BGMS stock news
This page provides real-time market news, earnings updates, and company announcements related to Bio Green Med Solution, Inc. (BGMS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-13 19:36 EST
Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Finviz2026-03-09 15:01:16
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-09 21:21:47
Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates
Finviz2026-03-09 22:21:44
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-10 11:07:14
Q32 Bio: Q4 Financial Overview
101 finance2026-03-10 11:24:08
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
Finviz2026-03-10 11:36:05
SAB Bio (SAB Biotherapeutics, Inc.) recently released further data from a Phase I clinical trial of its candidate drug SAB-142 in adult patients diagnosed with autoimmune type 1 diabetes.
老虎证券2026-03-10 11:42:58
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
Finviz2026-03-10 13:07:02
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-10 20:06:50
1 Consumer Stock with Competitive Advantages and 2 We Turn Down
101 finance2026-03-10 22:21:35
INmune Bio upgraded to Buy from Neutral at Lucid Capital
Finviz2026-03-11 10:16:00
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Finviz2026-03-11 10:34:12
KALA BIO's 70% Surge: Flow Analysis of the AI Pivot
101 finance2026-03-11 13:21:41
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
Finviz2026-03-11 19:18:40
Tevogen Bio Holdings Inc. is considering the acquisition of Sciometrix and Clinicus platforms to enhance its monitoring capabilities for Long Covid.
老虎证券2026-03-11 19:22:34
Q32 Bio Breaks Out — But Can It Hold the Momentum?
101 finance2026-03-11 19:54:44
Monte Rosa Therapeutics (GLUE) Likely to Surpass Earnings Forecasts: Will the Share Price Rise?
101 finance2026-03-12 15:03:59
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
Finviz2026-03-12 20:09:50
Korro Bio, Inc. (KRRO) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-13 00:27:38
Fresh Top Buy Recommendations for March 13
101 finance2026-03-13 10:27:46
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
Finviz2026-03-13 13:19:02
Wall Street experts predict Q32 Bio (QTTB) could surge by 103.55%: Is such a significant rise truly possible for this stock?
101 finance2026-03-13 15:01:22
Should You Buy, Sell, or Hold Bio-Techne Shares After a Wealth Manager Completely Exits Its Position?
101 finance2026-03-13 19:21:32
Q32 Bio: Q4 Financial Overview
101 finance2026-03-10 11:24:08
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
Finviz2026-03-10 11:36:05
SAB Bio (SAB Biotherapeutics, Inc.) recently released further data from a Phase I clinical trial of its candidate drug SAB-142 in adult patients diagnosed with autoimmune type 1 diabetes.
老虎证券2026-03-10 11:42:58
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
Finviz2026-03-10 13:07:02
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-10 20:06:50
1 Consumer Stock with Competitive Advantages and 2 We Turn Down
101 finance2026-03-10 22:21:35
INmune Bio upgraded to Buy from Neutral at Lucid Capital
Finviz2026-03-11 10:16:00
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Finviz2026-03-11 10:34:12
KALA BIO's 70% Surge: Flow Analysis of the AI Pivot
101 finance2026-03-11 13:21:41
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
Finviz2026-03-11 19:18:40
Tevogen Bio Holdings Inc. is considering the acquisition of Sciometrix and Clinicus platforms to enhance its monitoring capabilities for Long Covid.
老虎证券2026-03-11 19:22:34
Q32 Bio Breaks Out — But Can It Hold the Momentum?
101 finance2026-03-11 19:54:44
Monte Rosa Therapeutics (GLUE) Likely to Surpass Earnings Forecasts: Will the Share Price Rise?
101 finance2026-03-12 15:03:59
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
Finviz2026-03-12 20:09:50
Korro Bio, Inc. (KRRO) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-13 00:27:38
Fresh Top Buy Recommendations for March 13
101 finance2026-03-13 10:27:46
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
Finviz2026-03-13 13:19:02
Wall Street experts predict Q32 Bio (QTTB) could surge by 103.55%: Is such a significant rise truly possible for this stock?
101 finance2026-03-13 15:01:22
Should You Buy, Sell, or Hold Bio-Techne Shares After a Wealth Manager Completely Exits Its Position?
101 finance2026-03-13 19:21:32
BGMS stock chart
BGMS stock detailsBGMS stock price change
On the last trading day, BGMS stock closed at 0.95 USD, with a price change of 3.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more